GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $1.95 $2.64 Friday, 19th Apr 2024 CHRS stock ended at $2.07. This is 3.50% more than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 7.18% from a day low at $1.95 to a day high of $2.09.
90 days $1.93 $2.97
52 weeks $1.44 $8.33

Historical Coherus BioSciences prices

Date Open High Low Close Volume
2020-10-26 $17.44 $17.87 $17.27 $17.75 839 353
2020-10-23 $17.26 $17.78 $17.04 $17.59 732 910
2020-10-22 $16.50 $17.09 $16.44 $17.00 1 067 803
2020-10-21 $16.63 $16.87 $16.26 $16.56 922 067
2020-10-20 $17.24 $17.30 $16.51 $16.76 971 297
2020-10-19 $18.12 $18.15 $17.03 $17.08 1 513 820
2020-10-16 $18.09 $18.36 $17.93 $18.15 668 241
2020-10-15 $18.13 $18.25 $17.85 $18.09 551 731
2020-10-14 $18.80 $19.05 $18.26 $18.28 731 260
2020-10-13 $18.39 $18.87 $18.21 $18.85 1 328 787
2020-10-12 $18.65 $18.84 $18.41 $18.48 441 564
2020-10-09 $18.88 $18.90 $18.56 $18.61 856 593
2020-10-08 $18.17 $18.77 $17.99 $18.66 1 250 441
2020-10-07 $17.64 $18.02 $17.47 $17.83 967 243
2020-10-06 $17.39 $17.73 $17.01 $17.49 1 059 521
2020-10-05 $17.00 $17.46 $16.74 $17.29 898 937
2020-10-02 $17.75 $18.19 $16.94 $16.96 1 327 193
2020-10-01 $18.41 $18.59 $17.88 $18.07 866 763
2020-09-30 $18.52 $18.86 $18.15 $18.34 1 213 031
2020-09-29 $18.83 $19.02 $18.58 $18.81 451 116
2020-09-28 $18.57 $18.88 $18.20 $18.83 495 688
2020-09-25 $17.99 $18.68 $17.99 $18.41 575 271
2020-09-24 $18.01 $18.51 $17.75 $17.99 838 654
2020-09-23 $18.86 $19.00 $18.14 $18.19 756 176
2020-09-22 $19.20 $19.34 $18.16 $18.82 902 619
Click to get the best stock tips daily for free!

About Coherus BioSciences

Coherus BioSciences Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. The company also develops Toripalimab, a novel anti-PD-1 antibody for second-line treatment of melanoma ... CHRS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT